Haihe Biopharma Co., Ltd.

This study tests an experimental oral drug called HH2853 in people with peripheral T-cell lymphoma that has come back or not responded to prior treatments. The drug works by blocking certain proteins that help cancer cells grow. About 100 participants will receive the drug to see…

This study tests a new drug called CYH33 in people with rare conditions that cause abnormal growth of body parts or blood vessels. The drug targets a specific genetic change to help shrink overgrown tissue. The trial involves 141 adults and teens and will check for safety and eff…

This study tests an experimental drug called HH2853 for people with certain types of blood cancer (non-Hodgkin's lymphoma) or advanced solid tumors that have come back or not responded to treatment. The goal is to find the safest dose and see if the drug can shrink tumors. About …